Ionizing-radiation-responsive compositions, methods, and systems
View Patent ↗A method composition and system respond to ionizing, radiation to adjust biological activity. In some approaches the ionizing radiation is X-ray or extreme ultraviolet radiation that produces luminescent responses that induce biologically active responses.
1. A method, comprising:
delivering to at least one region a photosensitive biologically active material responsive to optical radiation in at least one optical wavelength band; and
irradiating a luminescent material in at least a portion of the at least one region with ionizing radiation having an irradiation spectrum, where the luminescent material is responsive to ionizing radiation in at least a portion of the irradiation spectrum to produce optical radiation in the at least one optical wavelength band;
wherein the luminescent material is endogenous to at least a portion of the at least one region.
2. The method of claim 1 , wherein the response of the luminescent material varies with radiation energy according to an excitation spectrum, and at least one peak in the irradiation spectrum substantially overlaps at least one peak in the excitation spectrum.
3. The method of claim 2 , wherein the excitation spectrum includes at least one photoelectric absorption edge.
4. The method of claim 2 , wherein a plurality of peaks in the irradiation spectrum substantially overlaps a plurality of peaks in the excitation spectrum.
5. The method of claim 4 , wherein the plurality of peaks in the excitation spectrum includes a plurality of photoelectric absorption edges.
6. The method of claim 1 , wherein the irradiating includes a plurality of ionizing radiation beams that overlap in at least a portion of the at least one region.
7. The method of claim 1 , wherein the photosensitive biologically active material includes:
a biologically active material; and
a photosensitive bioactivity-adjusting material disposed to provide an inhibition of biological activity of the biologically active material at a first inhibition level, the photosensitive bioactivity-adjusting material being responsive to the optical radiation in the at least one optical wavelength band to provide an inhibition of biological activity of the biologically active material at a second inhibition level less than the first inhibition level.
8. The method of claim 7 , wherein the biologically active material includes a pharmaceutical agent.
9. The method of claim 7 , wherein the biologically active material includes a substance capable of binding with a photolabile group, and the photosensitive bioactivity-adjusting material includes at least one photolabile group disposed to at least partially bind the substance and responsive to the optical radiation in the at least one optical wavelength band to at least partially unbind the substance.
10. The method of claim 7 , wherein the photosensitive bioactivity-adjusting material is disposed to at least partially retain at least a first portion of the biologically active material in the at least one region, and responsive to the optical radiation in the at least one optical wavelength band to at least partially allow release of at least the first portion of the biologically active material from the at least one region.
11. The method of claim 10 , wherein the photosensitive bioactivity-adjusting material includes at least one layer disposed to at least partially envelop at least a portion of the biologically active material.
12. The method of claim 10 , wherein the photosensitive bioactivity-adjusting material includes a matrix material disposed to at least partially enclose a plurality of portions of the biologically active material.
13. The method of claim 10 , wherein the photosensitive bioactivity-adjusting material includes a photolabile binding agent disposed to bind together a plurality of portions of the biologically active material, and responsive to the optical radiation in the at least one optical wavelength band to at least partially unbind the plurality of portions.
14. The method of claim 1 , wherein the photosensitive biologically active material is responsive to the optical radiation in the at least one optical wavelength band to become at least partially biologically inactive.
15. The method of claim 1 , wherein the photosensitive biologically active material includes a substance having at least one photoisomer, the at least one photoisomer being responsive to the optical radiation in the at least one optical wavelength band to at least partially convert from a first isomeric form to a second isomeric form.
16. The method of claim 1 , wherein the photosensitive biologically active material includes a binding partner of a protein, the photosensitive biologically active material being responsive to the optical radiation in the at least one optical wavelength band to modify an interaction between the binding partner and the protein.
17. The method of claim 16 , wherein the protein is a receptor and the binding partner is a receptor ligand having a probability of binding to the receptor that is changeable in response to the optical radiation in the at least one optical wavelength band.
18. The method of claim 16 , wherein the protein is an enzyme, and the binding partner is an enzyme inhibitor or an enzyme activator, the enzyme inhibitor or enzyme activator having a probability of binding to the enzyme that is changeable in response to the optical radiation in the at least one optical wavelength band.
19. The method of claim 1 , wherein the photosensitive biologically active material includes a photosensitizer.
20. The method of claim 19 , wherein the photosensitizer is a porphyrin, porphyrin derivative, chlorin, chlorin derivative, phthalocyanine, naphthalocyanine, cationic dye, flavin, flavin derivative, organometallic complex, fullerene, fullerene derivative, or semiconductor nanoparticle.